Health & Wellness
E11-06
Direct-to-consumer peptide and longevity commerce.
Stage — Early revenue
Pitch deck locked
- Target raise
- $1,000,000
- Minimum investment
- $100,000
- Hold period
- 4 years
- Anticipated revenue
- $5.6M revenue by year three
- Fees
- 2% annual management fee; 20% performance fee over an 8% preferred return
Compare other ventures
E11-01
$2.4M ARR by year three
E11-02
$3.1M ARR by year three
E11-03
$1.8M ARR by year three
E11-04
$4.2M gross bookings by year three
E11-05
$1.5M ARR by year three
E11-07
$2.0M net revenue by year three
E11-08
$2.3M net revenue by year three
E11-09
$1.6M ARR by year three
E11-10
$2.8M revenue by year three
E11-11
$3.4M ARR by year three
E11-12
$2.1M revenue per election cycle
Revenue expectations and investment requirements are illustrative estimates prepared for discussion only. They are not projections, offers, or solicitations to buy any security, and they are subject to change following diligence.